A Study of BGB-A445 in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer
Condition:   Non-Small Cell Lung Cancer Interventions:   Drug: BGB-A445;   Drug: Docetaxel;   Drug: Tislelizumab;   Drug: Sitravatinib;   Drug: Ramucirumab;   Drug: Selected Interventions;   Drug: BGB-15025 Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Total Neoadjuvant Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
Conditions:   Gastric Cancer;   Stomach Cancer;   GastroEsophageal Cancer;   Gastric Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma;   Advanced Gastric Adenocarcinoma;   Gastric Neoplasm;   Stomach Neoplasm;   Gastrointestinal Cancer;   Advanced Gastroesophageal Junction Ade nocarcinoma;   Advanced Gastric Carcinoma Interventions:   Drug: Docetaxel;   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: Fluorouracil Sponsor:   Ukrainian Society of Clinical Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

A Study of BGB-A445 in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer
Condition:   Non-Small Cell Lung Cancer Interventions:   Drug: BGB-A445;   Drug: Docetaxel;   Drug: Tislelizumab;   Drug: Sitravatinib;   Drug: Ramucirumab;   Drug: Selected Interventions;   Drug: BGB-15025 Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Total Neoadjuvant Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
Conditions:   Gastric Cancer;   Stomach Cancer;   GastroEsophageal Cancer;   Gastric Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma;   Advanced Gastric Adenocarcinoma;   Gastric Neoplasm;   Stomach Neoplasm;   Gastrointestinal Cancer;   Advanced Gastroesophageal Junction Ade nocarcinoma;   Advanced Gastric Carcinoma Interventions:   Drug: Docetaxel;   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: Fluorouracil Sponsor:   Ukrainian Society of Clinical Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

A Study of BGB-A445 in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer
Condition:   Non-Small Cell Lung Cancer Interventions:   Drug: BGB-A445;   Drug: Docetaxel;   Drug: Tislelizumab;   Drug: Sitravatinib;   Drug: Ramucirumab;   Drug: Selected Interventions;   Drug: BGB-15025 Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Total Neoadjuvant Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
Conditions:   Gastric Cancer;   Stomach Cancer;   GastroEsophageal Cancer;   Gastric Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma;   Advanced Gastric Adenocarcinoma;   Gastric Neoplasm;   Stomach Neoplasm;   Gastrointestinal Cancer;   Advanced Gastroesophageal Junction Ade nocarcinoma;   Advanced Gastric Carcinoma Interventions:   Drug: Docetaxel;   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: Fluorouracil Sponsor:   Ukrainian Society of Clinical Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

A Study of BGB-A445 in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer
Condition:   Non-Small Cell Lung Cancer Interventions:   Drug: BGB-A445;   Drug: Docetaxel;   Drug: Tislelizumab;   Drug: Sitravatinib;   Drug: Ramucirumab;   Drug: Selected Interventions;   Drug: BGB-15025 Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Total Neoadjuvant Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
Conditions:   Gastric Cancer;   Stomach Cancer;   GastroEsophageal Cancer;   Gastric Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma;   Advanced Gastric Adenocarcinoma;   Gastric Neoplasm;   Stomach Neoplasm;   Gastrointestinal Cancer;   Advanced Gastroesophageal Junction Ade nocarcinoma;   Advanced Gastric Carcinoma Interventions:   Drug: Docetaxel;   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: Fluorouracil Sponsor:   Ukrainian Society of Clinical Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

A Study of BGB-A445 in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer
Condition:   Non-Small Cell Lung Cancer Interventions:   Drug: BGB-A445;   Drug: Docetaxel;   Drug: Tislelizumab;   Drug: Sitravatinib;   Drug: Ramucirumab;   Drug: Selected Interventions;   Drug: BGB-15025 Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Total Neoadjuvant Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
Conditions:   Gastric Cancer;   Stomach Cancer;   GastroEsophageal Cancer;   Gastric Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma;   Advanced Gastric Adenocarcinoma;   Gastric Neoplasm;   Stomach Neoplasm;   Gastrointestinal Cancer;   Advanced Gastroesophageal Junction Ade nocarcinoma;   Advanced Gastric Carcinoma Interventions:   Drug: Docetaxel;   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: Fluorouracil Sponsor:   Ukrainian Society of Clinical Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

A Study of BGB-A445 in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer
Condition:   Non-Small Cell Lung Cancer Interventions:   Drug: BGB-A445;   Drug: Docetaxel;   Drug: Tislelizumab;   Drug: Sitravatinib;   Drug: Ramucirumab;   Drug: Selected Interventions;   Drug: BGB-15025 Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Total Neoadjuvant Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
Conditions:   Gastric Cancer;   Stomach Cancer;   GastroEsophageal Cancer;   Gastric Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma;   Advanced Gastric Adenocarcinoma;   Gastric Neoplasm;   Stomach Neoplasm;   Gastrointestinal Cancer;   Advanced Gastroesophageal Junction Ade nocarcinoma;   Advanced Gastric Carcinoma Interventions:   Drug: Docetaxel;   Drug: Oxaliplatin;   Drug: Leucovorin;   Drug: Fluorouracil Sponsor:   Ukrainian Society of Clinical Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

A Study of BGB-A445 in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer
Condition:   Non-Small Cell Lung Cancer Interventions:   Drug: BGB-A445;   Drug: Docetaxel;   Drug: Tislelizumab;   Drug: Sitravatinib;   Drug: Ramucirumab;   Drug: Selected Interventions;   Drug: BGB-15025 Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials